G
GLP1 Lawsuit
Mass Tort Case Review
Call
GLP-1 Drug Injury

Saxenda Lawsuit

Saxenda is Novo Nordisk's liraglutide injection for weight management — a first-generation GLP-1 drug. It produces the same class side effects driving the broader GLP-1 litigation.

Call (717) 724-7503

Free Confidential Case Review

No fee unless you win. Takes under 60 seconds.

Saxenda and the GLP-1 class

Liraglutide was the first daily GLP-1 weight-management drug widely prescribed in the U.S. Although newer drugs have taken market share, liraglutide users developed the same range of injuries: gastroparesis, pancreatitis, gallbladder disease, and ileus.

Qualifying injuries

Documented Saxenda use combined with hospitalization or formal diagnosis of a qualifying injury supports a claim. Earlier prescriptions may face statute-of-limitations issues — do not wait to seek review.

Frequently Asked Questions

Get your free, confidential case review

Takes under 60 seconds. No fee unless you win.

Free Confidential Case Review

No fee unless you win. Takes under 60 seconds.